ReviewJournal of clinical medicine2024
Navigating the Metaverse: A New Virtual Tool with Promising Real Benefits for Breast Cancer Patients.
Review in Journal of clinical medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- Three-Dimensional Scanning for Reduction Mammaplasty in Asymmetric Breast Hypertrophy.Aesthetic plastic surgery · 2026Article
- The Use of Metaverse in Radiology: A Systematic Review.Health science reports · 2025Review
- The role of virtual reality in breast cancer survivors: A scoping review.Preventive medicine reports · 2025Article
- Transformative Approaches in Breast Cancer Detection: Integrating Transformers into Computer-Aided Diagnosis for Histopathological Classification.Bioengineering (Basel, Switzerland) · 2025Article
- Artificial intelligence in oncology: promise, peril, and the future of patient-physician interaction.Frontiers in digital health · 2025Review
- Multimodal integration strategies for clinical application in oncology.Frontiers in pharmacology · 2025Review
- Artificial Intelligence in Breast Cancer Diagnosis and Surgical Decision-Making: An Updated and Comprehensive Overview of Precision and Personalization in Current Evidence.Cancer management and research · 2025Review
- Article
- The Role of Artificial Intelligence on Tumor Boards: Perspectives from Surgeons, Medical Oncologists and Radiation Oncologists.Current oncology (Toronto, Ont.) · 2024Review
- Immersive futures in healthcare: A mapping review of review articles on the metaverse.Digital healthReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BC, affecting both women and men, is a complex disease where early diagnosis plays a crucial role in successful treatment and enhances patient survival rates. The Metaverse, a virtual world, may offer new, personalized approaches to diagnosing and treating BC. Although Artificial Intelligence (AI) is still in its early stages, its rapid advancement indicates potential applications within the healthcare sector, including consolidating patient information in one accessible location. This could provide physicians with more comprehensive insights into disease details. Leveraging the Metaverse could facilitate clinical data analysis and improve the precision of diagnosis, potentially allowing for more tailored treatments for BC patients. However, while this article highlights the possible transformative impacts of virtual technologies on BC treatment, it is important to approach these developments with cautious optimism, recognizing the need for further research and validation to ensure enhanced patient care with greater accuracy and efficiency.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.